Showing results (221-230 of 288) with videos related to
Sort By:
Pageof 29
Pharmaceutical Patent Analyst|August 21, 2020
Two drugs facing key patent expirations and potential generic entry from July to August 2020Yali FriedmanPharmaceutical Patent Analyst|November 7, 2014
New spleen tyrosine kinase inhibitors: patent applications published during 2011-2013Atli Thorarensen, Neelu KailaPharmaceutical Patent Analyst|February 15, 2020
Patents targeting the Warburg effect for cancer therapy: an interview with William P KattWilliam P KattPharmaceutical Patent Analyst|January 19, 2019
Ensifentrine (RPL554): an inhaled 'bifunctional' dual PDE3/4 inhibitor for the treatment of asthma and chronic obstructive pulmonary diseaseMario Cazzola, Clive Page, Luigino Calzetta, et al.Pharmaceutical Patent Analyst|May 7, 2025
Development in medicinal chemistry via oxadiazole derivatives: patent spotlight 2020-2024Mehwish Solangi, Fouzia Naz, Syed Abid Ali, et al.Pharmaceutical Patent Analyst|May 15, 2025
Proteolysis targeting chimeras (PROTACs) in oncology: a review of patents and regulatory considerationsSowndharya M, Ramesh Joga, Kajal Gandhi, et al.Pharmaceutical Patent Analyst|October 8, 2014
First-to-invent versus first-to-file: impact of the AIATara Rachinsky, Clark Sullivan, Shubha Ghosh, et al.Pharmaceutical Patent Analyst|October 8, 2014
Advances and strategies in NADPH oxidase inhibitors and activators patentsPatrick PagePageof 29